Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy
NCT00713128
·
clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Sponsor
Steward St. Elizabeth's Medical Center of Boston, Inc.